Trial intelligence / Profile preview

Ziprasidone for Weight Management in Bipolar Disorder

NCT00472641Phase 4Completed

Sponsor
Stanford University
Start
Jan 2007
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ziprasidone in bipolar disorder (BD), sponsored by Stanford University. Started Jan 2007; status: completed.

02

Drugs

ziprasidone
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00472641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00472641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call